Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Applied Therapeutics, Inc.
13G/A
APLT · 03828A101
|
4.2% |
12/31/2025
Event 12/29/2025
|
|||
| Propel Bio Management, LLC | 4.2% | ||||
| Leen Kawas | 4.2% | ||||
| Richard Kayne and Suzanne Kayne Living Trust dtd 01/14/1999 | 0% | ||||
| Richard Kayne | 4.2% | ||||
| Propel Bio Partners LLC | 4.2% | ||||
|
Milestone Pharmaceuticals Inc.
13G
MIST · 59935V107
|
9.9% |
12/23/2025
Event 7/11/2025
|
|||
| Propel Bio Management, LLC | 9.9% | ||||
| Leen Kawas | 9.9% | ||||
| Richard Kayne | 9.9% | ||||
| Propel Bio Partners LLC | 9.9% | ||||